Toggle navigation
OpenPrescribing
Analyse
Area and Practice Dashboards
Practices
PCNs
Sub-ICB Locations
ICBs
Regional Teams
Hospitals
All England
Trends
Trends for BNF sections
Trends for chemicals
Trends for Drug Tariff and Concessions
Long term trends analysis
SICBL improvement radar
More
How to use
Stay in touch
FAQ
API
About
Research
dm+d
Blog
Privacy Policy
We are currently importing the latest prescribing data. You may see incomplete data across the site. Please check back in a couple of hours!
Prescribing measures
Show measures categorised as:
All Measures
Standard
Antimicrobial Stewardship
Cardiovascular system
Central Nervous system
Cost Saving
Diabetes
Efficacy
Erectile Dysfunction
Eye
Gastrointestinal system
Generic prescribing
Greener NHS
Infections
Mental Health
Mentioned in Papers
NHS England - items which should not routinely be prescribed in primary care
NICE
National medicines optimisation opportunities
Nutrition
Opioids
Pain
Reproductive system
Respiratory
Retired measures
Safety
See prescribing by all Sub-ICB Locations for:
Antibiotic stewardship: co-amoxiclav, cephalosporins & quinolones
Antibiotic stewardship: co-amoxiclav, cephalosporins & quinolones prescribing volume
Antibiotic stewardship: courses for amoxicillin 500mg greater than 15 capsules
Antibiotic stewardship: courses for doxycycline 100mg greater than 6 capsules/dispersible tablets
Antibiotic stewardship: fluoroquinolone items per 1000 patients
Antibiotic stewardship: Injectable preparations for the treatment of infection
Antibiotic stewardship: prescribing of trimethoprim vs nitrofurantoin
Antibiotic stewardship: three-day courses for uncomplicated UTIs
Antibiotic stewardship: volume of antibiotic prescribing
Anxiolytics and Hypnotics: Average Daily Quantity per 1000 patients
Anxiolytics and Hypnotics: Average Daily Quantity per item
Bile acid sequestrants, fibrates, nicotinic acid, and omega 3 fatty acids
Blood glucose testing lancets not included in NHS England commissioning recommendations
Blood glucose testing strips not included in NHS England commissioning recommendations
Ciclosporin and tacrolimus oral preparations prescribed generically
Cost of milk formulae for Cow's Milk Protein Allergy (CMPA) per listed patients aged 0-4
Diltiazem preparations (>60mg) prescribed generically
Environmental impact of inhalers - average carbon footprint per salbutamol inhaler
Environmental impact of inhalers - Prescribing of the less environmentally friendly Metered Dose Inhaler (MDI) (excluding salbutamol)
High-cost drugs for erectile dysfunction
High dose inhaled corticosteroids
High dose opioid items as percentage regular opioids
High dose opioids per 1000 patients
Higher dose Proton Pump Inhibitors (PPIs)
Items which should not routinely be prescribed in primary care - aliskiren
Items which should not routinely be prescribed in primary care - all items
Items which should not routinely be prescribed in primary care - amiodarone
Items which should not routinely be prescribed in primary care - bath and shower emollients
Items which should not routinely be prescribed in primary care - co-proxamol
Items which should not routinely be prescribed in primary care - dosulepin
Items which should not routinely be prescribed in primary care - doxazosin modified release
Items which should not routinely be prescribed in primary care - dronedarone
Items which should not routinely be prescribed in primary care - glucosamine and chondroitin
Items which should not routinely be prescribed in primary care - herbal medicines
Items which should not routinely be prescribed in primary care - homeopathy
Items which should not routinely be prescribed in primary care - immediate release fentanyl
Items which should not routinely be prescribed in primary care - insulin pen needles costing ≥£5 per 100 needles
Items which should not routinely be prescribed in primary care - lidocaine plasters
Items which should not routinely be prescribed in primary care - liothyronine (including Armour Thyroid and liothyronine combination products)
Items which should not routinely be prescribed in primary care - lutein and antioxidants
Items which should not routinely be prescribed in primary care - minocycline
Items which should not routinely be prescribed in primary care - omega-3 fatty acid compounds (excluding icosapent ethyl [Vazkepa®])
Items which should not routinely be prescribed in primary care - oxycodone and naloxone combination product
Items which should not routinely be prescribed in primary care - paracetamol and tramadol combination
Items which should not routinely be prescribed in primary care - perindopril arginine
Items which should not routinely be prescribed in primary care - rubefacients, benzydamine, mucopolysaccharide and cooling products
Items which should not routinely be prescribed in primary care - silk garments
Items which should not routinely be prescribed in primary care - travel vaccines
Items which should not routinely be prescribed in primary care - trimipramine
Low and medium intensity statins
Methotrexate 10 mg tablets
Non-preferred NSAIDs and COX-2 inhibitors
Possible excess quantities of semaglutide and tirzepatide
Prescribing of Amino Acid Formula (AAF) and Extensively Hydrolysed Formula (EHF))
Prescribing of continuous glucose monitoring sensors
Prescribing of gabapentin and pregabalin (DDD)
Prescribing of gluten free products
Prescribing of nimodipine
Prescribing of non-combination colecalciferol preparations
Prescribing of opioids (total oral morphine equivalence)
Prescribing of pregabalin (total mg)
Prescribing of tamoxifen
Probiotics that have been removed from the drug tariff
Proportion of Direct Acting Oral Anticoagulants (DOACs) not prescribed as generic rivaroxaban or generic apixaban tablets
Seven Day Prescribing for Long Term Conditions
Short acting beta agonist inhalers
Silver dressings
Soluble/effervescent forms of paracetamol and co-codamol
Sulfadiazine items per 1000 patients
Toothpaste Prescribing
Topical treatment of fungal nail infections
Vitamin B complex per 1000 patients
Vitamin B vs thiamine
Zuclopenthixol acetate prescribing in primary care
Feedback